Skip to content

Lucid Diagnostics LUCD Retained Earnings

Retained Earnings at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
-$238.81M-5.7%
Guardant Health logo
Guardant HealthGH
-$3.11B-16.2%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$505.56M-6.7%
Insight Molecular Diagnostics Inc. Common Stock logo
Insight Molecular Diagnostics Inc. Common StockIMDX
-$405.05M-13.4%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$505.13M-12.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$661.29M-16.9%

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's retained earnings?
Lucid Diagnostics (LUCD) reported retained earnings of -$297.96M in Q1 2026.
How has Lucid Diagnostics's retained earnings changed year-over-year?
Lucid Diagnostics's retained earnings decreased by 24.3% year-over-year, from -$239.78M to -$297.96M.
What is the long-term trend for Lucid Diagnostics's retained earnings?
Over 5 years (2020 to 2025), Lucid Diagnostics's retained earnings has grown at a 81.8% compound annual growth rate (CAGR), from -$13.83M to -$274.34M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.